ArticleInternational journal of biological sciences2026
Biomembrane-coated Nanoparticles Targeting circHIF1α Suppress Ovarian Cancer Metastasis and Cisplatin Resistance by Mediating System Xc⁻ Inactivation via SLC7A11/SLC3A2 to Induce Ferroptosis in Cancer Stem Cells.
Article in International journal of biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disulfidptosis-Associated Neurotoxicity Induced by Cadmium Under an Environmentally Relevant Cadmium Exposure Scenario.International journal of molecular sciences · 2026Article
- Bioengineering Strategies to Address Key Bottlenecks in Ferroptosis-Based Cancer Therapy: A Critical Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hypoxic tumor microenvironment (TME) drives malignant progression by increasing the activity of cancer stem cells (CSCs), whose iron-dependent metabolism not only maintains their stemness but also promotes drug resistance and ferroptosis resistance by activating key signaling pathways. This study revealed that hypoxia induces circHIF1α expression in CSCs and that its expression is significantly associated with chemotherapy resistance in patients. Functional experiments confirmed that circHIF1α enhances CSC stemness by regulating iron metabolism and driving cancer progression. The mechanism involves the dual regulation of ferroptosis: binding SLC3A2 to block lysosomal degradation and sponging miR-375 to abrogate its inhibition of SLC7A11, synergistically activating system Xc⁻-mediated glutathione synthesis for ferroptosis resistance. Additionally, circHIF1α can be transferred between cells in the TME via exosomes, promoting iron metabolic reprogramming and the spread of drug resistance. Based on this mechanism, we developed a cell membrane-coated siRNA nanodelivery system targeting circHIF1α and confirmed that the combination of this system with cisplatin exerted a synergistic antitumor effect. This study demonstrated that circHIF1α maintains ferroptosis resistance and a "high-iron metabolic" state in CSCs by preserving the antioxidant barrier, providing novel insights into the mechanism of circular RNAs and potential targets/strategies for overcoming chemotherapy resistance in ovarian cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.